SEC 13F Intelligence

Foresite Capital Management Vi LLC / KYMR

Foresite Capital Management Vi LLC’s Kymera Therapeutics Inc Position

Does Foresite Capital Management Vi LLC own Kymera Therapeutics Inc (KYMR)? Yes — 146.3K shares worth $12M (+2.65% of its 13F portfolio) as of Q1 2026.

Position Value
$12M
Q1 2026
Shares
146.3K
% of Portfolio
+2.65%
Quarters Held
6
currently held

Position History KYMR

Reported value by quarter
Q4 ’24: $6MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $6MQ2 ’25Q3 ’25: $8MQ3 ’25Q4 ’25: $11MQ4 ’25Q1 ’26: $12MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026146.3K$12M+2.65%
Q4 2025146.3K$11M+3.44%
Q3 2025146.3K$8M+3.20%
Q2 2025146.3K$6M+3.59%
Q1 2025146.3K$4M+2.19%
Q4 2024146.3K$6M+2.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of KYMR.